Antipodes Partners’s Vistra VST Stock Holding History

Antipodes Partners’s Portfolio VST Stock Details VST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,769,546	Closed	-$31.3M	–	34
2021 Q1	$31.3M	Buy	+1,769,546	New	+$35.2M	1.27%	24

Other funds holding VST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Antipodes Partners's VST Position: Q2 2021 in Review

Antipodes Partners sold out of Vistra (VST) in Q2 2021, closing a stake of 1,769,546 shares — an estimated $31.3M sold.

Antipodes Partners first reported a position in VST in Q1 2021 and held it in 1 quarter. The position peaked at $31.3M in Q1 2021. 375 funds tracked by Wall St. Rank hold VST as of Q2 2021.

Antipodes Partners reported no remaining Vistra position as of Q2 2021 after selling out during the quarter.
Antipodes Partners sold 1,769,546 Vistra shares in Q2 2021, an estimated $31.3M.
Antipodes Partners first reported a position in Vistra in Q1 2021 and held it in 1 quarter.
Antipodes Partners's Vistra position peaked at $31.3M in Q1 2021.
375 funds tracked by Wall St. Rank held Vistra as of Q2 2021.

Based on Antipodes Partners's 13F filing for Q2 2021, filed 17 Aug 2021.